Bal Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
One of their notable products is BEPOTASTINE BESILATE, with a corresponding US DMF Number 27386.
Remarkably, this DMF maintains an Active status since its submission on August 16, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 12, 2013, and payment made on September 10, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II